Skip to content

Claude Code / MCP·Privacy Policy

FDA clears the Sparrow Ascent — Spark Biomedical

Back to Spark Biomedical

Milestone

Oct 2023

FDA clears the Sparrow Ascent

DP

Jan 22, 2025

Second generation wearable neurostimulation platform cleared for opioid withdrawal management. Reducing COGS by 75% over gen 1.